Big News! The FDA has officially approved Novo Nordisk’s Ozempic to treat chronic kidney disease (CKD) in patients with type 2 diabetes (T2D), expanding its already critical role in managing metabolic health.
https://www.cnbc.com/2025/01/28/novo-nordisks-ozempic-wins-fda-approval-for-chronic-kidney-disease.html
https://www.cnbc.com/2025/01/28/novo-nordisks-ozempic-wins-fda-approval-for-chronic-kidney-disease.html
Comments